Safety and Effectiveness of the Yaari Extractor for Management of Shoulder Dystocia (NCT05913609) | Clinical Trial Compass
RecruitingNot Applicable
Safety and Effectiveness of the Yaari Extractor for Management of Shoulder Dystocia
United States80 participantsStarted 2023-11-15
Plain-language summary
Prospective, multi-center, single arm with historical control, to verify the safety and effectiveness of the Yaari Extractor used by board certified or board eligible U.S. OB/GYN physicians in the management of shoulder dystocia.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Subject 18 years of age or older at time of consent.
✓. Subject planning on vaginal birth.
✓. Singleton pregnancy in vertex presentation.
✓. Full-term pregnancy having completed 37 weeks or more gestational weeks.
✓. Able and willing to provide written informed consent prior to enrollment.
✓. In the opinion of the Investigator, the subject has sufficient mental capacity to understand the informed consent form (ICF).
✓. Subject with fetus experiencing shoulder dystocia as defined by ACOG Practice Bulletin 178 "Shoulder dystocia is most commonly diagnosed as failure to deliver the fetal shoulder(s) with gentle downward traction on the fetal head, requiring additional maneuvers to effect delivery."
Exclusion criteria
✕. Patients who have undergone attempted delivery using ancillary standard of care maneuvers, to include first-line maneuvers (McRoberts ± suprapubic pressure with downward traction on the fetal head), prior to use of the Yaari Extractor. (NOTE: Hyperflexion of the hips or legs is allowed prior to and during use of the Yaari Extractor.)
✕. Cesarean section is planned for the patient.
✕. Obstetric contraindications to vaginal birth.
✕. Subject carrying fetus with known significant chromosomal or structural anomalies.
What they're measuring
1
Number of successful neonate deliveries with the Yaari Extractor device
Timeframe: immediately after the intervention
2
Time interval (minutes) from the diagnosis of the shoulder dystocia until the neonate's delivery
Timeframe: immediately after the intervention
3
Maternal and neonatal adverse events
Timeframe: through study completion, an average of 5 days
. Clinically estimated fetal weight ≥5kg in non-diabetic subjects.
✕. Clinically estimated fetal weight ≥4.5kg in subjects with diabetes.
✕. Subject has any general health condition or systemic disease that may represent, in the opinion of the Investigator, a potential increased risk associated with device use or pregnancy.
✕. Bleeding disorders, such as thrombocytopenia, von Willebrand's disease, bleeding disorder currently using anticoagulation medication, etc.